Table 2 Performance of ExoVita pancreas classifier in the training and validation sets.

From: Development of a blood-based extracellular vesicle classifier for detection of early-stage pancreatic ductal adenocarcinoma

Cohort

Training set (95% CI)a

Validation set (95% CI)a

N

Sensitivity, %

Specificity, %

N

Sensitivity, %

Specificity, %

PDAC cases

105

93.3 (86.9–96.7)

 

30

90.0 (74.4–96.5)

 

Stage I

39

94.9 (83.1–98.6)

10

100.0 (72.2–100)

Stage II

66

92.4 (83.5–96.7)

20

85.0 (64.0–94.8)

Controls

545

 

91.0 (88.3–93.1)

83

 

92.8 (85.1–96.6)

  1. aTwo-sided 95% Wilson confidence intervals.
Back to article page